Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

Clinical trial NCT06643793 · RECRUITING

Trial details

NCT number: NCT06643793
Sponsor: Affiliated Hospital of Nantong University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms Malignant

Start date: 2024-11-04
Primary completion: 2026-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.